Realloys Inc. appoints Grassi & Co. as new auditor, dismisses Victor Mokuolo CPA

Realloys Inc. dismissed its independent auditor Victor Mokuolo CPA PLLC and appointed Grassi & Co. CPAs, P.C. for the 2026 audit; the outgoing auditor’s reports for 2024 and 2025 carried no adverse opinions, only a going-concern paragraph. The filing also said there were no disagreements or prohibited consultations with the new auditor. Separately, the company continues to advance its rare earth strategy with a planned $40 million Ohio metallization facility targeting 30 tonnes of dysprosium and 15 tonnes of terbium annually, plus a MOU for up to 10% offtake from the Sheep Creek project.

Analysis

The most interesting read-through is not the audit change itself, but what it signals about capital formation risk in a microcap with a long-dated industrial story. When a company in a pre-revenue buildout swaps auditors while carrying a going-concern warning, the market usually assigns a higher probability to future dilution, delayed milestones, or both. That matters more here because the equity thesis depends on expensive, multi-year execution in a sector where credibility with strategic counterparties and grant-givers is an asset.

The second-order winner is the Montana rare-earth developer mentioned in the supply agreement: any credible non-China downstream processing narrative tends to pull valuation up the chain, especially if the offtake is framed as strategic rather than purely commercial. But the flip side is that this kind of story can compress into a tradeable squeeze only if financing visibility improves; otherwise, the market often rerates the whole theme lower after initial enthusiasm as investors realize capex, qualification, and working-capital needs are still ahead. In other words, the asset is “story-positive” but “funding-sensitive.”

The macro overlay is important: rare-earth supply-chain names are increasingly being bid on geopolitical scarcity rather than near-term cash flow, so the stock can stay elevated longer than fundamentals justify. The contrarian risk is that the market overestimates the speed at which a small-cap can convert government/defense adjacency into meaningful revenue; the critical window is 6-18 months, not days. Any sign of delayed construction, permit friction, or softer strategic demand would likely hit multiples first and estimates later.

For the broader sector, this is a reminder that the best asymmetric exposure may sit one level upstream or downstream rather than in the headline name. If the company can actually secure feedstock and processing milestones, suppliers and offtake-linked peers should outperform on lower execution risk. If not, the equity remains a high-beta financing instrument disguised as an industrial buildout.

Key Decisions for Investors

• Avoid chasing ALOY on the news; if already long, reduce into strength and require a financing update before re-adding. Risk/reward is poor while the business remains pre-scale and dilution risk dominates.
• Long USCMF vs short a basket of higher-execution-risk rare-earth juniors for a 3-6 month relative-value trade. The thesis is that credible feedstock access will be rewarded more than pure project promotion.
• If forced to own the theme, prefer staged entries only after tangible de-risking milestones: land, permitting, equipment orders, or project financing. Until then, treat the name as event-driven rather than investment-grade.
• Use ALOY implied volatility for downside protection if liquidity permits: buy 2-4 month puts or put spreads into strength to hedge the common post-rally fade seen in story stocks with going-concern baggage.
• Monitor for an acquisition/strategic investment catalyst over the next 1-2 quarters; if none emerges, the probability of a capital raise increases materially and should cap upside.